BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3193214)

  • 1. Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma.
    Baulieu JL; Guilloteau D; Baulieu F; Le Floch O; Chambon C; Pourcelot L; Besnard JC
    J Nucl Med; 1988 Dec; 29(12):2008-13. PubMed ID: 3193214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [131I]metaiodobenzylguanidine treatment of a malignant paraganglioma.
    Baulieu JL; Guilloteau D; Calais G; Lefloch O; Besnard JC
    J Nucl Biol Med (1991); 1991; 35(4):313-4. PubMed ID: 1823844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up].
    Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T
    Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic para-aortic paraganglioma by surgery, radiotherapy and I-131 mIBG.
    Ball AB; Tait DM; Fisher C; Sinnett HD; Harmer CL
    Eur J Surg Oncol; 1991 Oct; 17(5):543-6. PubMed ID: 1936304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization and treatment of familial malignant nonfunctional paraganglioma with iodine-131 MIBG: report of two cases.
    Khafagi F; Egerton-Vernon J; van Doorn T; Foster W; McPhee IB; Allison RW
    J Nucl Med; 1987 Apr; 28(4):528-31. PubMed ID: 2437268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant paraganglioma of the mediastinum: a further diagnostic and therapeutic use of radiolabelled mIBG.
    Cornford EJ; Wastie ML; Morgan DA
    Br J Radiol; 1992 Jan; 65(769):75-8. PubMed ID: 1486373
    [No Abstract]   [Full Text] [Related]  

  • 10. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
    Hoefnagel CA; Schornagel J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
    Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
    Hoefnagel CA; Taal BG; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of [131]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma.
    Colombo L; Lomuscio G; Vignati A; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):300-4. PubMed ID: 1823841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear medicine therapy of pheochromocytoma and paraganglioma.
    Troncone L; Rufini V
    Q J Nucl Med; 1999 Dec; 43(4):344-55. PubMed ID: 10731785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy.
    Inoue T; Yoshinaga K; Morita K; Shiga T; Kanegae K; Hirata K; Okamoto S; Tamaki N
    Ann Nucl Med; 2007 Jul; 21(5):307-10. PubMed ID: 17634850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
    Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
    J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.